Results 11 to 20 of about 29,786,765 (312)

Comparative evaluation of Savanna HSV 1+2/VZV multiplex assay and Simplexa HSV 1&2 and VZV direct kits for rapid molecular detection of HSV-1, HSV-2, and VZV [PDF]

open access: yesMicrobiology Spectrum
Herpes simplex virus (HSV-1 and HSV-2) and varicella-zoster virus (VZV) cause cutaneous and mucocutaneous lesions. Primary infection and secondary reactivations affect the mouth, genitalia, and dermis at other bodily regions.
Blake W. Buchan   +12 more
doaj   +2 more sources

HSV-1 as a Potential Driver of Alzheimer’s Disease [PDF]

open access: yesPathogens
Herpes simplex virus type 1 (HSV-1) is a continuous health challenge, and current antiviral treatments cannot cure the virus. As life expectancy continues to increase worldwide, HSV-1 should remain a focus to minimize its associated health complications ...
Dar-Yin Li, Eun Seok Choi, Xiaoyong Bao
doaj   +2 more sources

Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread [PDF]

open access: yesVirology Journal, 2009
The frequent oral shedding of herpes simplex virus type 1 (HSV-1) in the absence of clinical disease suggests that symptomatic HSV-1 recurrences may be inhibited by the mucosal environment.
Välimaa Hannamari   +3 more
doaj   +3 more sources

Epigallocatechin Gallate-Modified Silver Nanoparticles Show Antiviral Activity against Herpes Simplex Type 1 and 2

open access: yesViruses, 2023
(1) Background: Epigallocatechin gallate (EGCG) has been recognized as a flavonoid showing antiviral activity against various types of DNA and RNA viruses.
Malgorzata Krzyzowska   +8 more
doaj   +1 more source

Application of Environment-Friendly Rhamnolipids against Transmission of Enveloped Viruses Like SARS-CoV2

open access: yesViruses, 2021
In the face of new emerging respiratory viruses, such as SARS-CoV2, vaccines and drug therapies are not immediately available to curb the spread of infection.
Ling Jin, Wendy Black, Teresa Sawyer
doaj   +1 more source

Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study

open access: yesBMJ Open, 2023
Objectives To assess the seroprevalence of herpes simplex virus (HSV) types 1 and 2 in patients infected with HIV in Nigeria.Design Cross-sectional design from January to June 2019.Setting Federal Teaching Hospital, Ebonyi State, Nigeria.Participants A ...
Euslar Nnenna Onu   +10 more
doaj   +1 more source

Hsp90 Inhibitors Prevent HSV-1 Replication by Directly Targeting UL42-Hsp90 Complex

open access: yesFrontiers in Microbiology, 2022
Herpes simplex virus type I (HSV-1) is a member of the Alphaherpesvirinae family, which could initiate labial herpes caused by the reactivation of HSV-1 primary infection, and secondary infection even causes herpes encephalitis.
Shurong Qin   +29 more
doaj   +1 more source

Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1 [PDF]

open access: yesGene Therapy, 1997
Herpes simplex virus type-1 (HSV-1) has been used for gene delivery in the nervous system for the treatment of brain tumors and other neurological diseases. In most protocols, recombinant viruses containing the gene of interest are directly injected into the brain.
Q, Wang, J, Guo, W, Jia
openaire   +2 more sources

“Non-Essential” Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review

open access: yesViruses, 2020
Viruses encode for structural proteins that participate in virion formation and include capsid and envelope proteins. In addition, viruses encode for an array of non-structural accessory proteins important for replication, spread, and immune evasion in ...
Christos Dogrammatzis   +2 more
doaj   +1 more source

Detection of herpes simplex virus in oral tongue squamous cell carcinoma

open access: yesFrontiers in Pharmacology, 2023
Introduction: Oral tongue squamous cell carcinoma (OTSCC) is the most common cancer of the oral cavity. Contradictory results have been observed on the involvement of herpes simplex virus 1 (HSV-1) in oral squamous cell carcinomas.
Tiina Koivikko   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy